C5aR1 Signaling Promotes Region and Age Dependent Synaptic Pruning in Models of Alzheimer's Disease

Overview

Journal bioRxiv

Date 2023 Oct 24

PMID 37873302

Authors

Angela Gomez-Arboledas

Maria I Fonseca

Eniko Kramar

Shu-Hui Chu

Nicole Schartz

Purnika Selvan

Marcelo A Wood

Andrea J Tenner

Affiliations

Soon will be listed here.

Abstract

Introduction: Synaptic loss is a hallmark of Alzheimer's disease (AD) that correlates with cognitive decline in AD patients. Complement-mediated synaptic pruning has been associated with this excessive loss of synapses in AD. Here, we investigated the effect of C5aR1 inhibition on microglial and astroglial synaptic pruning in two mouse models of AD.

Methods: A combination of super-resolution and confocal and tridimensional image reconstruction was used to assess the effect of genetic ablation or pharmacological inhibition of C5aR1 on the Arctic48 and Tg2576 models of AD.

Results: Genetic ablation or pharmacological inhibition of C5aR1 rescues the excessive pre-synaptic pruning and synaptic loss in an age and region dependent fashion in two mouse models of AD, which correlates with improved long-term potentiation (LTP).

Discussion: Reduction of excessive synaptic pruning is an additional beneficial outcome of the suppression of C5a-C5aR1 signaling, further supporting its potential as an effective targeted therapy to treat AD.

References

Lui H, Zhang J, Makinson S, Cahill M, Kelley K, Huang H . Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell. 2016; 165(4):921-35. PMC: 4860138. DOI: 10.1016/j.cell.2016.04.001. View

Crane J, Baiquni G, Sullivan R, Lee J, Sah P, Taylor S . The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres. J Neuroinflammation. 2009; 6:34. PMC: 2780381. DOI: 10.1186/1742-2094-6-34. View

Podlesny-Drabiniok A, Marcora E, Goate A . Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics. Trends Neurosci. 2020; 43(12):965-979. PMC: 9080913. DOI: 10.1016/j.tins.2020.10.002. View

Mecca A, ODell R, Sharp E, Banks E, Bartlett H, Zhao W . Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [ C]UCB-J. Alzheimers Dement. 2022; 18(12):2527-2536. PMC: 9381645. DOI: 10.1002/alz.12582. View

Weinhard L, Di Bartolomei G, Bolasco G, Machado P, Schieber N, Neniskyte U . Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction. Nat Commun. 2018; 9(1):1228. PMC: 5964317. DOI: 10.1038/s41467-018-03566-5. View

Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S . Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996; 274(5284):99-102. DOI: 10.1126/science.274.5284.99. View

Brown G, Neher J . Microglial phagocytosis of live neurons. Nat Rev Neurosci. 2014; 15(4):209-16. DOI: 10.1038/nrn3710. View

Terry R, Masliah E, Salmon D, Butters N, DeTeresa R, Hill R . Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991; 30(4):572-80. DOI: 10.1002/ana.410300410. View

Carpanini S, Harwood J, Baker E, Torvell M, The Gerad Consortium , Sims R . The Impact of Complement Genes on the Risk of Late-Onset Alzheimer's Disease. Genes (Basel). 2021; 12(3). PMC: 8003605. DOI: 10.3390/genes12030443. View

10.

Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole G . Inflammation and Alzheimer's disease. Neurobiol Aging. 2000; 21(3):383-421. PMC: 3887148. DOI: 10.1016/s0197-4580(00)00124-x. View

11.

Fonseca M, Chu S, Hernandez M, Fang M, Modarresi L, Selvan P . Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflammation. 2017; 14(1):48. PMC: 5340039. DOI: 10.1186/s12974-017-0814-9. View

12.

Merkel P, Jayne D, Wang C, Hillson J, Bekker P . Evaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomitantly With Rituximab or Cyclophosphamide/Azathioprine: Protocol for a Randomized,.... JMIR Res Protoc. 2020; 9(4):e16664. PMC: 7175182. DOI: 10.2196/16664. View

13.

Cribbs D, Velazquez P, Soreghan B, Glabe C, Tenner A . Complement activation by cross-linked truncated and chimeric full-length beta-amyloid. Neuroreport. 1998; 8(16):3457-62. DOI: 10.1097/00001756-199711100-00009. View

14.

Shi Q, Chowdhury S, Ma R, Le K, Hong S, Caldarone B . Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice. Sci Transl Med. 2017; 9(392). PMC: 6936623. DOI: 10.1126/scitranslmed.aaf6295. View

15.

Benoit M, Hernandez M, Dinh M, Benavente F, Vasquez O, Tenner A . C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity. J Biol Chem. 2012; 288(1):654-65. PMC: 3537064. DOI: 10.1074/jbc.M112.400168. View

16.

Selkoe D . Alzheimer's disease is a synaptic failure. Science. 2002; 298(5594):789-91. DOI: 10.1126/science.1074069. View

17.

Lehrman E, Wilton D, Litvina E, Welsh C, Chang S, Frouin A . CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development. Neuron. 2018; 100(1):120-134.e6. PMC: 6314207. DOI: 10.1016/j.neuron.2018.09.017. View

18.

Dejanovic B, Huntley M, De Maziere A, Meilandt W, Wu T, Srinivasan K . Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies. Neuron. 2018; 100(6):1322-1336.e7. DOI: 10.1016/j.neuron.2018.10.014. View

19.

Woodruff T, Nandakumar K, Tedesco F . Inhibiting the C5-C5a receptor axis. Mol Immunol. 2011; 48(14):1631-42. DOI: 10.1016/j.molimm.2011.04.014. View

20.

Shen Y, Lue L, Yang L, Roher A, Kuo Y, Strohmeyer R . Complement activation by neurofibrillary tangles in Alzheimer's disease. Neurosci Lett. 2001; 305(3):165-8. DOI: 10.1016/s0304-3940(01)01842-0. View